Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects

• Published in: PloS one 2011-12, Vol.6 (12), p.e28872-e28872
• Main Authors: Posch, Maximilian G, Waldmuller, Stephan, Müller, Melanie, Scheffold, Thomas, Fournier, David, Andrade-Navarro, Miguel A, De Geeter, Bernard, Guillaumont, Sophie, Dauphin, Claire, Yousseff, Dany, Schmitt, Katharina R, Perrot, Andreas, Berger, Felix, Hetzer, Roland, Bouvagnet, Patrice, Özcelik, Cemil
• Format: Article
• Language: English
• Subjects: Acids; Actin; Adult; Analysis; Atrial septal defects; Biology; Cardiac Myosins - genetics; Cardiology; Cardiomyopathy; Cardiovascular disease; Child; Child, Preschool; Congenital diseases; Data mining; Defects; Development and progression; Disease - genetics; DNA binding proteins; Etiology; Family; Female; Gene mutation; Genes; Genetic aspects; Genetic disorders; Genotyping; Heart; Heart diseases; Heart Septal Defects, Atrial - genetics; Heart surgery; Heterozygote; Homology; Humans; Male; Medical research; Medicine; Middle Aged; Missense mutation; Muscle proteins; Mutation; Mutation - genetics; Myosin; Myosin Heavy Chains - genetics; Patients; Pediatrics; Pedigree; Phenotype; Risk factors; Sarcomeres - genetics; Sarcomeres - pathology; Smooth muscle; Studies; Transcription (Genetics); Transcription factors; Vascular surgery
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0028872

Secundum-type atrial septal defects (ASDII) account for approximately 10% of all congenital heart defects (CHD) and are associated with a familial risk. Mutations in transcription factors represent a genetic source for ASDII. Yet, little is known about the role of mutations in sarcomeric genes in ASDII etiology. To assess the role of sarcomeric genes in patients with inherited ASDII, we analyzed 13 sarcomeric genes (MYH7, MYBPC3, TNNT2, TCAP, TNNI3, MYH6, TPM1, MYL2, CSRP3, ACTC1, MYL3, TNNC1, and TTN kinase region) in 31 patients with familial ASDII using array-based resequencing. Genotyping of family relatives and control subjects as well as structural and homology analyses were used to evaluate the pathogenic impact of novel non-synonymous gene variants. Three novel missense mutations were found in the MYH6 gene encoding alpha-myosin heavy chain (R17H, C539R, and K543R). These mutations co-segregated with CHD in the families and were absent in 370 control alleles. Interestingly, all three MYH6 mutations are located in a highly conserved region of the alpha-myosin motor domain, which is involved in myosin-actin interaction. In addition, the cardiomyopathy related MYH6-A1004S and the MYBPC3-A833T mutations were also found in one and two unrelated subjects with ASDII, respectively. No mutations were found in the 11 other sarcomeric genes analyzed. The study indicates that sarcomeric gene mutations may represent a so far underestimated genetic source for familial recurrence of ASDII. In particular, perturbations in the MYH6 head domain seem to play a major role in the genetic origin of familial ASDII.